Correlation of biologically effective dose and the tumor control in Stage I (<5 cm) non-small cell lung cancer with stereotactic ablative radiotherapy: a single institutional cohort study.

about

Correlation of biologically effective dose and the tumor control in Stage I (<5 cm) non-small cell lung cancer with stereotactic ablative radiotherapy: a single institutional cohort study.

Item

http://www.wikidata.org/entity/Q52763791

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Correlation of biologically ef ...... le institutional cohort study.

@en

Correlation of biologically effective dose and the tumor control in Stage I

@nl

type

Item

label

Correlation of biologically ef ...... le institutional cohort study.

@en

Correlation of biologically effective dose and the tumor control in Stage I

@nl

prefLabel

Correlation of biologically ef ...... le institutional cohort study.

@en

Correlation of biologically effective dose and the tumor control in Stage I

@nl

P1476

Correlation of biologically ef ...... le institutional cohort study.

@en

P2093

Chul-Kyu Park

http://www.w3.org/2001/XMLSchema#string

In-Jae Oh

http://www.w3.org/2001/XMLSchema#string

Jae-Uk Jeong

http://www.w3.org/2001/XMLSchema#string

Ju-Young Song

http://www.w3.org/2001/XMLSchema#string

Mee Sun Yoon

http://www.w3.org/2001/XMLSchema#string

Sung-Ja Ahn

http://www.w3.org/2001/XMLSchema#string

Taek-Keun Nam

http://www.w3.org/2001/XMLSchema#string

Wan Jeon

http://www.w3.org/2001/XMLSchema#string

Woong-Ki Chung

http://www.w3.org/2001/XMLSchema#string

Young-Chul Kim

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancer

Stereotactic body radiation therapy for inoperable early stage lung cancer.

Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry.

Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer.

Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study.

The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage

A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly.

P304

144-152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JJCO/HYX172

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29194510

http://www.w3.org/2001/XMLSchema#string